Thomas A. Raffin Lumos Pharma, Inc. (LUMO) insider trading activity

LUMO Quotes by TradingView

Thomas A. Raffin is Director of LUMOS PHARMA, INC.. Currently has a direct ownership of 9,406 shares of LUMO, which is worth approximately $21,821. The most recent transaction as insider was on Aug 25, 2022, when has been sold 1,150 shares (Common Stock) at a price of $8.46 per share, resulting in proceeds of $9,729. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.41K
0% 3M change
0% 12M change
Total Value Held $21,821

Thomas A. Raffin Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 25 2022
BUY
Open market or private purchase
$9,729 $8.46 p/Share
1,150 Added 10.89%
9,406 Common Stock
May 20 2021
BUY
Grant, award, or other acquisition
-
367 Added 4.26%
8,256 Common Stock

Also insider at

AKYA
Akoya Biosciences, Inc. Healthcare
Director
TAR

Thomas A. Raffin

Director
Austin, TN

Track Institutional and Insider Activities on LUMO

Follow LUMOS PHARMA, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LUMO shares.

Notify only if

Insider Trading

Get notified when an Lumos Pharma, Inc. insider buys or sells LUMO shares.

Notify only if

News

Receive news related to LUMOS PHARMA, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LUMO